Skip to main content

Fidelity — Portfolio, Page 10

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

257
Companies
$32.4B
Total invested
$171.2M
Avg. check
51
Industries
Biotechnology 12Therapeutics 4Pharmaceutical 4Health Care 3Medical 3Genetics 2+45 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 217240 of 257
CareMax
January 2022

CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors.

Health Care · Miami$1.0M Post Ipo Equity
SalioGen Therapeutics
January 2022

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.

Biotechnology · Burlington$115.0M Series B
Starry
October 2021

Starry is an internet company that creates easy-to-use Wi-Fi products and radical ways to get Internet service.

Hardware · Boston$150.0M Post Ipo Debt
Veterinary Emergency Group
September 2021

Veterinary Emergency Group provides animals and their families with timely medical care for acute problems at times when pets need it.

Customer Service · White Plains$100.0M Series C
Skyhawk Therapeutics
September 2021

Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.

Biotechnology · Waltham$133.0M Series Unknown
AgBiome
September 2021

AgBiome discovers and develops innovative biological and trait products for crop protection.

Agriculture · Raleigh$116.0M Series D
T-knife
August 2021

T-knife is a developer of T cell receptors intended for T cell therapy of cancer.

Biotechnology · Berlin$110.0M Series B
Doma
July 2021

Doma is an insurtech platform that uses machine intelligence to remove friction from residential real estate transactions.

Artificial Intelligence (AI) · Miami$300.0M Post Ipo Equity
Riskified
July 2021

Riskified enables businesses to realize the full potential of eCommerce by making it safe, accessible, and frictionless.

E-Commerce · New YorkPost Ipo Equity
Aristea Therapeutics
July 2021

Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.

Biotechnology · San Diego$63.0M Series B
Graphite Bio
March 2021

Graphite Bio is a next-generation gene editing company that is driven to apply our breakthrough technology.

Biotechnology · South San Francisco$150.7M Series B
Xsight Labs
March 2021

Xsight Labs is a new startup in the field of manufacturing chip-set semiconductors for data center and automotive sector.

Machinery Manufacturing · Kiryat GatSeries D
Gemini Therapeutics
February 2021

Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.

Biopharma · Cambridge$95.0M Post Ipo Equity
Kaleido BioSciences
February 2021

Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.

Biotechnology · Bedford$60.4M Post Ipo Equity
Rush Street Interactive
December 2020

Rush Street Interactive offers online casino and sports betting in the U.S.

Casino · Chicago$160.0M Post Ipo Equity
Skillz
December 2020

Skillz is a marketplace platform for competition-based mobile games.

Developer Platform · Las Vegas$159.0M Post Ipo Equity
Full Truck Alliance
November 2020

Full Truck Alliance is an IT service and IT consulting platform that facilitates transactions between shippers and truckers.

Apps · Nanjing$1.7B Private Equity
ACV
September 2020

ACV is a full-service dealer marketplace that runs online automotive auctions.

Apps · Buffalo$55.0M Series E
Antengene
July 2020

Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.

Biopharma · Shanghai$97.0M Series C
GetSwift
March 2020

GetSwift is a smart delivery platform.

Business Intelligence · Denver$45.0M Post Ipo Equity
Akouos
March 2020

Akouos is a biotechnology company focusing on restoring and preserving hearing.

Biotechnology · Boston$105.0M Series B
Aimmune Therapeutics
February 2020

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

Biotechnology · Brisbane$200.0M Post Ipo Equity
ClearX
February 2020

Blockchain-based enterprise marketplaces to seamlessly automate order to cash cycles with no disputes

Enterprise · Singapore$13.0M Series A
Translate Bio
January 2020

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.

Biotechnology · Lexington$125.0M Post Ipo Equity

Where Fidelity invests

Biotechnology12
Therapeutics4
Pharmaceutical4
Health Care3
Medical3
Genetics2

About Fidelity's portfolio

How many companies has Fidelity invested in?

Fidelity has invested in 257 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Fidelity invest in?

Fidelity's top investment sectors include Biotechnology, Therapeutics, Pharmaceutical, Health Care, Medical. The firm invests across 51 different industry categories.

What is Fidelity's largest investment?

Among tracked funding rounds, Full Truck Alliance received $1.7B in a Private Equity round. Fidelity's total known invested capital is $32.4B.

What is the average investment size for Fidelity?

Fidelity's average investment size is $171.2M across its portfolio of 257 companies.

What are Fidelity's most recent investments?

Recent Fidelity portfolio additions include CareMax, SalioGen Therapeutics, Starry, Veterinary Emergency Group, Skyhawk Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 257 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →